Benefit of complete revascularization in patients with multivessel coronary disease in the drug-eluting stent era

JW Chung, KH Park, MH Lee, KW Park, JS Park… - Circulation …, 2012 - jstage.jst.go.jp
Background: The benefit of complete (CR) vs. incomplete revascularization (IR) with drug-
eluting stent (DES), unlike with bypass grafting, is not well established in patients with …

Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents

AP Banning, S Westaby, MC Morice… - Journal of the American …, 2010 - jacc.org
Objectives: This study was designed to compare contemporary surgical revascularization
(coronary artery bypass graft surgery [CABG]) versus TAXUS Express (Boston Scientific …

Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease

Bari Investigators - Circulation, 1997 - cir.nii.ac.jp
抄録< jats: p>< jats: italic> Background</jats: italic> Patients with diabetes mellitus have
increased morbidity and mortality after coronary revascularization. The Bypass Angioplasty …

Everolimus eluting stents versus coronary artery bypass graft surgery for patients with diabetes mellitus and multivessel disease

S Bangalore, Y Guo, Z Samadashvili… - Circulation …, 2015 - Am Heart Assoc
Background—In patients with diabetes mellitus and multivessel disease, coronary artery
bypass graft surgery and percutaneous coronary intervention are treatment options …

Medical treatment and revascularization options in patients with type 2 diabetes and coronary disease

GBJ Mancini, ME Farkouh, MM Brooks… - Journal of the American …, 2016 - jacc.org
Background: There are scant outcomes data in patients with type 2 diabetes and stable
coronary artery disease (CAD) stratified by detailed angiographic burden of CAD or left …

Impact of diabetes on five-year outcomes of patients with multivessel coronary artery disease

W Hueb, BJ Gersh, F Costa, N Lopes… - The Annals of thoracic …, 2007 - Elsevier
BACKGROUND: Diabetes mellitus is a major cause of coronary artery disease. Despite
improvement in the management of patients with stable coronary artery disease, diabetes …

Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus …

GR Dagenais, J Lu, DP Faxon, K Kent, RM Lago… - Circulation, 2011 - Am Heart Assoc
Background—In the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI
2D) trial, an initial strategy of coronary revascularization and optimal medical treatment …

CABG the clear choice for patients with diabetes and multivessel disease

DL Bhatt - The Lancet, 2018 - thelancet.com
Whether coronary artery bypass grafting (CABG) or percutaneous coronary intervention
(PCI) is the preferred revascularisation method in patients with multivessel coronary artery …

CABG versus PCI: greater benefit in long-term outcomes with multiple arterial bypass grafting

RH Habib, KR Dimitrova, SA Badour… - Journal of the American …, 2015 - jacc.org
Background: Treatment of multivessel coronary artery disease with traditional single-arterial
coronary artery bypass graft (SA-CABG) has been associated with superior intermediate …

Impact of completeness of revascularization on long-term cardiovascular outcomes in patients with type 2 diabetes mellitus: results from the Bypass Angioplasty …

L Schwartz, M Bertolet, F Feit, F Fuentes… - Circulation …, 2012 - Am Heart Assoc
Background—Patients with diabetes have more extensive coronary disease than those
without diabetes, resulting in more challenging percutaneous coronary intervention or …